Perrigo shares tumble as CEO leaves for Valeant, guidance cut again By: MarketWatch April 25, 2016 at 10:51 AM EDT Perrigo says it has reduced pricing expectations in its prescription drug segment. Read More >> Related Stocks: Mylan Perrigo Valeant Pharmaceuticals International, Inc.